These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 25978310)

  • 21. [The -108 C/T polymorphism in paraoxonase 1 gene in Chinese patients with polycystic ovary syndrome].
    Zhang F; Liu HW; Fan P; Bai H; Song Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):24-8. PubMed ID: 21355294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of SOD2 A16V and PON2 S311C polymorphisms with polycystic ovary syndrome in Chinese women.
    Liu Q; Liu H; Bai H; Huang W; Zhang R; Tan J; Guan L; Fan P
    J Endocrinol Invest; 2019 Aug; 42(8):909-921. PubMed ID: 30607774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association analysis between the tag single nucleotide polymorphisms of DENND1A and the risk of polycystic ovary syndrome in Chinese Han women.
    Zhu YN; Zhang YT; Liu Q; Shen SM; Zou X; Cao YX; Wang WJ; Yi L; Gao Q; Yang WD; Wang Y
    BMC Med Genet; 2020 Jan; 21(1):14. PubMed ID: 31941453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between FSHR polymorphisms and polycystic ovary syndrome among Chinese women in north China.
    Wu XQ; Xu SM; Liu JF; Bi XY; Wu YX; Liu J
    J Assist Reprod Genet; 2014 Mar; 31(3):371-7. PubMed ID: 24390680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Verification of a ZBTB16 variant in polycystic ovary syndrome patients.
    Yang J; Zhao R; Li L; Li G; Yang P; Ma J; Zhao S; Zhao H
    Reprod Biomed Online; 2020 Oct; 41(4):724-728. PubMed ID: 32773339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential association of DENND1A genetic variants with polycystic ovary syndrome in Tunisian but not Bahraini Arab women.
    Dallel M; Sarray S; Douma Z; Hachani F; Al-Ansari AK; Letaifa DB; Mahjoub T; Almawi WY
    Gene; 2018 Mar; 647():79-84. PubMed ID: 29325736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Han Chinese polycystic ovary syndrome risk variants in women of European ancestry: relationship to FSH levels and glucose tolerance.
    Saxena R; Georgopoulos NA; Braaten TJ; Bjonnes AC; Koika V; Panidis D; Welt CK
    Hum Reprod; 2015 Jun; 30(6):1454-9. PubMed ID: 25904635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Family-based analysis of adiponectin gene polymorphisms in Chinese Han polycystic ovary syndrome.
    Zhang W; Wei D; Sun X; Li J; Yu X; Shi Y; Chen ZJ
    Fertil Steril; 2014 May; 101(5):1419-23. PubMed ID: 24559720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms and haplotypes of the TGF-β1 gene are associated with risk of polycystic ovary syndrome in Chinese Han women.
    Yang J; Zhong T; Xiao G; Chen Y; Liu J; Xia C; Du H; Kang X; Lin Y; Guan R; Yan P; Xiao J
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():1-7. PubMed ID: 25594618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry.
    Welt CK; Styrkarsdottir U; Ehrmann DA; Thorleifsson G; Arason G; Gudmundsson JA; Ober C; Rosenfield RL; Saxena R; Thorsteinsdottir U; Crowley WF; Stefansson K
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1342-7. PubMed ID: 22547425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of adiponectin and resistin gene polymorphisms in South Indian women with polycystic ovary syndrome.
    Nambiar V; Vijesh VV; Lakshmanan P; Sukumaran S; Suganthi R
    Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():82-8. PubMed ID: 26995146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.
    Lin S; Huiya Z; Bo L; Wei W; Yongmei G
    Endocrine; 2009 Dec; 36(3):503-9. PubMed ID: 19856137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphism of methylenetetrahydrofolate reductase is associated with insulin resistance in Egyptian women with polycystic ovary syndrome.
    Nsrallah AA; Abd-El Fatah AH; Ahmed HS
    J Gene Med; 2019 Apr; 21(4):e3076. PubMed ID: 30743312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of CYP17A1 gene -34T/C polymorphism with polycystic ovary syndrome in Han Chinese population.
    Li L; Gu ZP; Bo QM; Wang D; Yang XS; Cai GH
    Gynecol Endocrinol; 2015 Jan; 31(1):40-3. PubMed ID: 25208301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leutinizing hormone/choriogonadotropin receptor and follicle stimulating hormone receptor gene variants in polycystic ovary syndrome.
    Almawi WY; Hubail B; Arekat DZ; Al-Farsi SM; Al-Kindi SK; Arekat MR; Mahmood N; Madan S
    J Assist Reprod Genet; 2015 Apr; 32(4):607-14. PubMed ID: 25649397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of LHCGR polymorphisms in polycystic ovary syndrome: an association study.
    Singh S; Kaur M; Beri A; Kaur A
    Sci Rep; 2023 Dec; 13(1):22841. PubMed ID: 38129424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
    Ma CS; Lin Y; Zhang CH; Xu H; Li YF; Zhang SC; Tan Y; Quan S; Xing FQ
    Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of apoC1 genotypes on the hormonal levels, metabolic profile and PAF-AH activity in Chinese women with polycystic ovary syndrome.
    Zhang R; Liu Q; Liu H; Bai H; Zhang Y; Guan L; Fan P
    Lipids Health Dis; 2018 Apr; 17(1):77. PubMed ID: 29636060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genome-wide association studies of Chinese individuals.
    Brower MA; Jones MR; Rotter JI; Krauss RM; Legro RS; Azziz R; Goodarzi MO
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E182-6. PubMed ID: 25303487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relevance of
    Daghestani MH; Daghestani MH; Daghistani M; Ambreen K; Almuammar MN; Al Neghery LM; Warsy AS
    Br J Biomed Sci; 2020 Oct; 77(4):185-190. PubMed ID: 32031919
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.